In recent years, GLP-1 weight loss drugs like Ozempic and Wegovy have become the talk of the town, offering benefits beyond just shedding pounds. While these drugs are primarily aimed at weight loss, some men are noticing an unexpected bonus: increased girth below the belt.
The GLP-1 hormone, which plays a key role in regulating insulin production and suppressing hunger, seems to be having surprising effects on male physiology as well.
For those unfamiliar, GLP-1 works by promoting insulin production after eating, lowering blood sugar levels, and slowing down digestion, making you feel full longer. Ozempic, designed for diabetes treatment, and Wegovy, aimed at obesity, both utilize semaglutide, a GLP-1 agonist that mimics the hormone’s natural effects. This powerful combo seems to be doing wonders for more than just waistlines.
A recent study from Diabetes.co.uk revealed that average penile length in the UK increased by 0.46 inches between 2022 and 2024, coinciding with the introduction of Ozempic and Wegovy. As these drugs gained popularity, several social media users started sharing stories of improved ‘performance,’ fueling the buzz. Some speculated that enhanced blood flow due to weight loss could be the culprit. Others, like Dr. Richard Viney, a consultant urological surgeon at the Queen Elizabeth Hospital, suggest that the real cause could be the removal of fat around the pelvic area, making the penis appear longer.
While the potential benefits are enticing, it’s important to note that GLP-1 drugs come with side effects such as nausea, diarrhea, constipation, and even suicidal thoughts. Therefore, anyone considering these drugs should consult a doctor before use. But for those already on the medication, this unexpected bonus could give them plenty to brag about.